AYSEGUL A SAHIN to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications AYSEGUL A SAHIN has written about In Situ Hybridization, Fluorescence.
Connection Strength
0.246
-
HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger. Cancer. 2005 Mar 01; 103(5):900-5.
Score: 0.042
-
Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated? Clin Breast Cancer. 2023 06; 23(4):415-422.
Score: 0.036
-
Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy. PLoS One. 2020; 15(11):e0241775.
Score: 0.031
-
Biologic and clinical significance of HER-2/neu (cerbB-2) in breast cancer. Adv Anat Pathol. 2000 May; 7(3):158-66.
Score: 0.030
-
Comparing breast biomarker status between routine immunohistochemistry and FISH studies and Oncotype DX testing, a study of 610 cases. Breast J. 2018 11; 24(6):889-893.
Score: 0.027
-
Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarray. Oncotarget. 2017 02 14; 8(7):10845-10857.
Score: 0.024
-
Aberrations in pseudoautosomal regions (PARs) found in infertile men with Y-chromosome microdeletions. J Clin Endocrinol Metab. 2011 Apr; 96(4):E674-9.
Score: 0.016
-
Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34. Cancer Res. 2007 May 01; 67(9):4104-12.
Score: 0.012
-
Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. Cancer Epidemiol Biomarkers Prev. 2003 Dec; 12(12):1518-22.
Score: 0.010
-
HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma. Am J Clin Pathol. 2000 Jun; 113(6):852-9.
Score: 0.007
-
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 1998 Oct; 20(2):189-93.
Score: 0.007
-
Interphase cytogenetics in mammographically detected breast lesions. Hum Pathol. 1996 Apr; 27(4):330-5.
Score: 0.006